UNSPSC 51143008: Dimiracetam

This classification denotes a neuroprotective agent with the molecular formula C6H8N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 4AW7F70MZO chemically known as (+/-)-dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione but generally known as dimiracetam, which bears US NIH Compound Identifier 65955. European Medicines Agency schedules Dimiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07186MIG.

UNSPSC 51143008 Dimiracetam, a Commodity code, addresses procurement of this specific pharmaceutical agent by state and local health systems, corrections departments, and medical facilities. Dimiracetam is a nootropic compound used clinically to support cognitive function and memory in patient populations, typically procured through pharmaceutical supply contracts serving hospitals, mental health centers, correctional medical units, and long-term care facilities. State and local governments purchase dimiracetam as part of broader formulary management and pharmaceutical inventory operations, often bundled into larger medication procurement vehicles or obtained through state pharmacy benefit managers and group purchasing organizations.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted RFPs, RFQs, ITBs, or other solicitation activity in the opportunity block, no issuing bodies, geographic concentration, or representative recent procurements can be identified. The absence of recent activity for this Commodity code suggests either limited demand across state and local jurisdictions, sourcing through established long-term contracts or blanket purchase agreements that do not generate new solicitations, or infrequent standalone procurement events for dimiracetam.